Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare
Spero Therapeutics Inc. Cash on Hand 2016–2025
Spero Therapeutics Inc. annual cash on hand history from 2016 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Spero Therapeutics Inc. cash on hand as of December 31, 2025: 40.3M, a 23.87% decrease year-over-year.
- Spero Therapeutics Inc. cash on hand for 2025 were 40.3M, a 23.87% decrease from 2024.
- Spero Therapeutics Inc. cash on hand for 2024 were 52.9M, a 30.71% decrease from 2023.
- Spero Therapeutics Inc. cash on hand for 2023 were 76.3M, a 30.04% decrease from 2022.
- Spero Therapeutics Inc. cash on hand for 2022 were 109.1M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Spero Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $40 |
| 2024 | $53 |
| 2023 | $76 |
| 2022 | $109 |
| 2021 | $113 |
| 2020 | $85 |
| 2019 | $30 |
| 2018 | $34 |
| 2017 | $87 |
| 2016 | $10 |
Spero Therapeutics Inc. Cash on Hand — FAQ
Spero Therapeutics Inc. (SPRO) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SPRO's cash on hand history?
The chart and table above show Spero Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.